COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report

By the beginning of the global pandemic, SARS-CoV-2 infection has dramatically impacted on oncology daily practice. In the current oncological landscape, where immunotherapy has revolutionized the treatment of several malignancies, distinguishing between COVID-19 and immune-mediated pneumonitis can...

Descripción completa

Detalles Bibliográficos
Autores principales: Dipasquale, Angelo, Persico, Pasquale, Lorenzi, Elena, Rahal, Daoud, Santoro, Armando, Simonelli, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880093/
https://www.ncbi.nlm.nih.gov/pubmed/33574054
http://dx.doi.org/10.1136/jitc-2020-001870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880093/
https://www.ncbi.nlm.nih.gov/pubmed/33574054
http://dx.doi.org/10.1136/jitc-2020-001870

Ejemplares similares